High expression of pseudouridine synthase 7 (PUS7) prognosticates the poor outcome of individuals with glioblastoma and inhibition of PUS7-mediated pseudouridine modification restrained the glioblastoma stem cell (GSC) tumorigenesis (7). Here, PUS7 is linked to glioblastoma.